Dear Colleagues,

With the new prequalification of ROTASIIL, manufactured by Serum Institute of India, there are now four globally available rotavirus vaccines. Both ROTAVAC, prequalified in January 2018, and ROTASIIL provide different formulations and presentations from other globally available rotavirus vaccines and should have an impact on costs. All four vaccines prequalified by WHO have shown similar efficacy rates in low-income settings. See below for materials on all prequalified rotavirus vaccine products.

There will be much to discuss at the 2018 meeting of the American Society of Tropical Medicine & Hygiene, where ROTA Council will convene a panel on progress, challenges, and the road ahead with rotavirus disease and vaccines. Read more about this and other updates below. 

Mathu Santosham

Chair, ROTA Council

In this Issue

  • Important Updates
  • Upcoming Events
  • New Research
  • Advocacy Tools
  • Member Publications
  • Recent Media
Read the Full Progress Update

The ROTA Council was created in collaboration with an advisory group of 24 child health leaders from around the world. We promote the use of rotavirus vaccines as part of a comprehensive approach to addressing diarrheal disease.

logo-ivac logo-jhu
  • Stay up to date with the Rotavirus Organization of Technical Allies (ROTA)
    Sign up for the latest updates on rotavirus immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.
  • This field is for validation purposes and should be left unchanged.
Subscribe to our newsletter